Diabetic complications and the genetics of signal transduction. A study of retinopathy in NIDDM

Disease Markers

Volumn 13, Issue 3, 1997, Pages 169-176

  Lucarini, N ^a   Bottini, N ^b   Antonacci, E ^c   Borgiani, P ^b   Faggioni, G ^a   Gloria Bottin, F ^b,d  

^a UNIVERSITY OF CAMERINO   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c USSL Penne   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Diabetic retinopathy; Genetic interactions diabetes; Retinopathy genetics; Signal transduction

Indexed keywords

ACID PHOSPHATASE; ADENOSINE DEAMINASE; INSULIN;

ADULT; AGED; ARTICLE; BLOOD GROUP ABO SYSTEM; CONTROLLED STUDY; DIABETIC RETINOPATHY; DYSLIPIDEMIA; FEMALE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0030819262     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Ahmad, F., Goldstein, B.J. (1995a). Alteration in specific protein-tyrosine phosphatases accompany insulin resistance of streptozoticin diabetes. Am. J. Physiol., 268, 932-940.
2. Ahmad, F., Goldstein, B.J. (1995b). Increased abundance of specific skeletal muscle protein-tyrosine phosphatases in a genetic model of insulin resistant obesity and diabetes mellitus. Metabolism. 44, 1175-1184.
3. Ahmad, F., Meyerovitch, J., Goldstein, B.J. (1995). Osmotic loading of neutralizing antibodies demonstrates a role for protein-tyrosine phospatase 1B in negative regulation of the insulin action pathway. J. Biochem. Chem., 270, 20503-20508.
4. Arch, J.R.S., Newsholme, E.A. (1978). The control of the metabolism and the hormonal role of adenosine. Essays Biochem., 14, 82-183.
5. Battistuzzi, G., Scozzari, R., Santolamazza, P., Terrenato, L., Modiano, G. (1974). Comparative activity of red cell adenosine deaminase allele forms. Nature. 251, 711-712.
6. Bottini, E., Carapella, E., Cataldi, L., Nicotra, M., Lucarelli, P., Lucarini, N., Pascone, R., Gloria-Bottini, F. (1981). Adenosine deaminase polymorphism. Associations at clinical level suggest a role in cell functions and immune reactions. J. Med. Genet., 18, 331-334.
7. Bottini, E. (1985). Interaction between adenosine deaminase and ABO system polymorphisms: effects on intrauterine survival and reproduction. Exp. Clin. Immunogenet., 2, 70-76.
8. Brown, C.M., Collis, M.G. (1982). Evidence for an A2/R4 adenosine receptor in the guinea pig trachea. Br. J. Clin. Pharmacol., 76, 381-387.
9. Dissing, J., Johnsen, A.H., Sensabaugh, G.F. (1991). Human red cell acid phosphatase (ACPI). J. Biol. Chem., 266, 20619-20625.
10. Fischer, E.H., Charbonneau, H., Tonks, N.K. (1991). Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes. Science, 253, 401-406.
11. Gloria-Bottini, F., Gerlini, G., Lucarini, N., Borgiani, P., Amante, A., La Torre, M., Antonacci, E., Bottini, E. (1996). Phosphotyrosine protein phosphatases and diabetic pregnancy: an association between low molecular weight acid phosphatase and degree of glycemic control. Experientia, 52, 340-343.
12. Goldslein, B.J. (1992). Protein-tyrosine phospatases and the regulation of insulin action. J. Cell. Biochem., 48, 33-42.
13. Harris, H., Hopkinson, D.A. (1976). Handbook of enzyme electrophoresis in human genetics. Amsterdam: Elsevier.
14. Holgate, S.T., Mann, J.S., Cushley, M.J. (1984). Adenosine as a bronchoconstrictor mediator in astma and its antagonism by metylxanthines. J. Allergy Clin. Immunol., 74, 302-306.
15. Ishii, H., Jirousek, M.R., Koya, D., Takagi, C., Xia, P., Clermont, A., Bursell, S.-E., Kern, T.S., Ballas L.M., Heath, W.F., Stramm, L.E., Feener, E.P., King, G.L. (1996). Amelioration of vascular dysfunctions in diabetic rats by an oral PKC β inhibitor. Science. 272, 728-731.
16. Lazaruk, K.D.A., Dissing, J., Sensabaugh, G.F. (1993). Exon structure at the human ACP1 locus supports alternative splicing model for f and s isozyme generation. Biochem. Biophys. Rev. Comm., 196, 440-446.
17. Londos C., Wolff, J. (1977). Two distinct adenosine-sensitive sites on adenylate cyclase. Proc. Natl. Acad. Sci. USA, 74, 5482-5486.
18. Lucarini, N., Borgiani, P., Ballarini, P., Bottini, E. (1989). Erythrocyte acid phosphatase (ACPI) acitivity: in vitro modulation by adenosine and inosine and effects of adenosine deaminase (ADA) polymorphism. Hum. Genet., 81, 185-187.
19. Lucarini, N., Nicotra, M., Gloria-Bottini, F., Borgiani, P., Amante, A., Muttinelli, C., Signoretti, F., La Torre, M., Bottini, F. (1995). Interaction between ABO blood groups and ADA genetic polymorphism during intrauterine life. Hum. Genet., 96, 527-531.
20. Mansfield, H., Sensabaugh, G.F. (1978). Red cell acid phosphatase modulation of activity by purities. In: Brewer G.F. (Ed.). The red cell. New York, Liss. pp. 233-247.
21. McGuire, M.C., Fields, R.M., Nyomba, B.L., Ratz, I., Bogardus, C., Tonks, N.K., Sommercorn, J. (1991). Abnormal regulation of protein tyrosine phosphatase activities in skeletal muscle of insulin-resistant humans. Diabetes, 40, 939-942.
22. Meyerovitch, J., Bacher, J.M., Kahn, C.R. (1989). Hepatic phosphotyrosine phosphatase activity and its alteration in diabetic rats. J. Clin. Invest., 84, 976-983.
23. Nadiv, O., Shinitzky, M., Manu, H., Hecht, D., Roberts, C.T., Leroith, D., Zick, Y. (1994). Elevated protein tyrosine phosphatase activity and increased membrane viscosity are associated with impaired activation of the insulin receptor kinase in old rats. Biochem. J., 298, 443-450.
24. Porte, D. Jr., Schwartz, M.W. (1996). Diabetes complications: why is glucose potentially toxic? Science, 272, 699-700.
25. Scholz, W., Knuszmann, R., Daweke, H. (1975). Distribution of blood and serum protein group characteristics in patients with diabetes. Diabetologia, 11, 77-82.
26. Spencer, N., Hopkinson, D.A., Harris, H. (1968). Adenosine deaminase polymorphism in man. Ann. Hum. Genet., 32, 9-14.
27. SPSS/PC+ Version 5.0 (1992). Chicago: SPSS Inc.
28. Stefani, M., Caselli, A., Bucciantini, M., Pazzagli, L., Dolfi, F., Camici, G., Manao, G., Ramponi, G. (1993). Dephosphorylation of tyrosine phosphorylated synthetic peptides by rat liver phosphotyrosine protein phosphatase isoenzymes. FEBS. 326, 131-134.
29. Taylor, M., Kerr, D. (1996). Diabetes control and complications: a coming of AGE. Lancet. 347, 485.
30. Wo, Y.P., McCormack, A.L., Shabanowitz., J., Hunt, D.F., Davis, J.P., Mitchell, G.L., Van Etten, R.L. (1992). Sequencing, cloning and expression of human red cell-type acid phosphatase, a cytoplasmatic phosphotyrosyl protein phosphatase. J. Biol. Chem., 267, 10856-10865.
31. Wolffenbuttel, B.H.R., Giordano, H.D., Founds, W., Bucala, R. (1996). Long-term assessment of glucose control by haemoglobin-AGE measurement. Lancet, 347, 49-50.
32. Zhang, M., Van Etten, R.L., Stauffacher, C.V. (1994). Crystal structure of bovine hearth phosphotyrosyl phosphatase at 2.2-A resolution. Biochemistry, 33, 11097-11105.